DE3152931C2 - - Google Patents
Info
- Publication number
- DE3152931C2 DE3152931C2 DE3152931A DE3152931A DE3152931C2 DE 3152931 C2 DE3152931 C2 DE 3152931C2 DE 3152931 A DE3152931 A DE 3152931A DE 3152931 A DE3152931 A DE 3152931A DE 3152931 C2 DE3152931 C2 DE 3152931C2
- Authority
- DE
- Germany
- Prior art keywords
- acid
- group
- methyl
- cephem
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/48—Methylene radicals, substituted by hetero rings
- C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
R² für eine 1,2,4-Triazolyl- oder 2-(1,2,3,4-Tetrazolyl)- gruppe steht, die substituiert sein können durch einen Substituenten, ausgewählt aus der Gruppe Halogen,
C1-5-Alkyl, Phenyl, Amino, C1-5-Alkylthio, C2-3-Alkanoylamino, C1-5-Alkoxycarbonyl und C1-5-Alkoxycarbonyl- C1-5-Alkyl, wobei die 1,2,4-Triazolylgruppe an die Exomethylengruppe in 3-Position des Cephemrings über eine Kohlenstoff-Stickstoff-Bindung geknüpft ist und R⁴ für eine Aminogruppe steht, welche gegebenenfalls durch eine übliche Aminoschutzgruppe geschützt sein kann (DE-P 31 37 854.4).
1-(1,2,4-Triazolyl), 2-(1,2,4-Triazolyl) und 4-(1,2,4-Triazolyl).
- (1) Aliphatische Reste: z. B. Alkylgruppen und Alkenylgruppen;
- (2) alicyclische Reste: z. B. Cycloalkylgruppen und Cycloalkenylgruppen;
- (3) aromatische Reste: z. B. Arylgruppen;
- (4) araliphatische Reste: z. B. Aralkylgruppen;
- (5) heterozyklische Reste: z. B. heterozyklische Gruppen;
- (6) Acylgruppen: Acylgruppen, welche von organischen Carbonsäuren abgeleitet werden können, z. B. von aliphatischen Carbonsäuren; alicyclischen Carbonsäuren; alicycloaliphatischen Carbonsäure; aromatisch- substituierten aliphatischen Carbonsäuren; aromato- oxy-aliphatischen Carbonsäuren; aromato-thio-aliphatischen Carbonsäuren; heterozyklisch-substituierten aliphatischen Carbonsäuren; heterozyklisch-oxy- aliphatischen Carbonsäuren; oder heterozyklisch-thio- aliphatischen Carbonsäuren; organischen Carbonsäuren; in denen ein aromatischer Ring, eine aliphatische Gruppe oder eine alicyclische Gruppe mit der Carbonylgruppe über ein Sauerstoffatom, ein Stickstoffatom oder ein Schwefelatom verbunden ist; aromatische Carbonsäuren; heterozyklische Carbonsäure.
- (a) Ester: Ester, welche üblicherweise auf dem Gebiet der Penicilline und Cephalosporine hergestellt werden, und zwar insbesondere die in Bezug auf R¹ erwähnten Ester.
- (b) Anhydride der Carboxylgruppe mit N-Hydroxysuccinimid, N-Hydroxyphthalimid, Dimethylhydroxylamin, Diethylhydroxylamin, 1-Hydroxypiperidin oder Oxim
- (c) Amide: Säureamide, N-substituierte Säureamide und N,N-disubstituierte Säureamide sind alle mitumfaßt. Besonders erwähnt seien N-Alkylsäureamide wie N-Methylsäureamid oder N-Ethylsäureamid; N-Arylsäureamid wie N-Phenylsäureamid; N,N-Dialkylsäureamide wie N,N-Dimethylsäureamid, N,N-Diethylsäureamid oder N-Ethyl-N-methylsäureamid; Säureamide mit Imidazol, 4-substituiertem Imidazol oder Triazolopyridon.
Diphenylmethyl-7-[2-(2-chloracetamidothiazol-4-yl)- glyoxylamido]-3-[(3-chlor-1,2,4-triazolyl)methyl]- Δ³-cephem-4-carboxylat
Diphenylmethyl-7-[2-(2-chloracetamidothiazol-4-yl)- 2-(syn)-methoxyiminoacetamido]-3-[(3-chlor-1,2,4- triazolyl)methyl]-Δ³-cephem-4-carboxylat
Diphenylmethyl-7-[2-(2-aminothiazol-4-yl)-2-(syn)- methoxyiminoacetamido]-3-[(3-chlor-1,2,4-triazolyl)- methyl]-Δ³-cephem-4-carboxylat
1-Pivaloyloxyethyl-7-[(2-aminothiazol-4-yl)-glyoxylamido]- 3-[2-(5-methyl-1,2,3,4-tetrazolyl)-methyl]- Δ³-cephem-4-carboxylat; Schmelzpunkt: 106 bis 109°C (Zers.)
1-Pivaloyloxyethyl-7-[2-(2-aminothiazol-4-yl)- 2-(syn)-methoxyiminoacetamido]-3-[2-(5-methyl-1,2,3,4- tetrazolyl)-methyl]-Δ³-cephem-4-carboxylat; Schmelzpunkt: 127 bis 130°C (Zers.).
1-Pivaloyloxyethyl-7-[2-(2-aminothiazol-4-yl)- 2-(syn)-methoxyiminoacetamido]-3-[(3-chlor-1,2,4-triazolyl)- methyl]-Δ³-cephem-4-carboxylat; Schmelzpunkt: 145 bis 147°C.
1-Pivaloyloxyethyl-7-[(2-formamidothiazol-4-yl)- glyoxylamido]-3-[2-(5-methyl-1,2,3,4-tetrazolyl)-methyl]- Δ³-cephem-4-carboxylat;
1-Pivaloyloxyethyl-7-[2-(2-formamidothiazol-4- yl)-2-(syn)-methoxyiminoacetamido]-3-[(3-chlor-1,2,4- triazolyl)-methyl]-Δ³-cephem-4-carboxylat.
Schmelzpunkt: 151 bis 154°C.
1-Pivaloyloxyethyl-7-[2-(2-formamidothiazol-4- yl)-2-(syn)-methoxyamido]-3-[2-(5-methyl-1,2,3,4-tetrazolyl)- methyl]-Δ³-cephem-4-carboxylat.
Schmelzpunkt: 203 bis 205°C (Zers.).
Claims (1)
- Verwendung von 7-[(2-Aminothiazol-4-yl)-glyoxylamido]-3- cephem-4-carbonsäuren der allgemeinen Formel oder ein Salz derselben worin
R¹ für ein Wasserstoffatom oder eine übliche Carboxyl- Schutzgruppe steht,
R² für eine 1,2,4-Triazolyl- oder 2-(1,2,3,4-Tetrazolyl)- gruppe steht, die substituiert sein können durch einen Substituenten, ausgewählt aus der Gruppe Halogen, C₁-C₅- Alkyl, Phenyl, Amino, C₁-C₅-Alkylthio, C₂-C₃-Alkonylamino, C₁-C₅-Alkoxycarbonyl und C₁-C₅-Alkoxycarbonyl-C₁-C₅-Alkyl-, wobei die 1,2,4-Triazolylgruppe an die Exomethylengruppe in 3-Position des Cephemrings über einen Kohlenstoff-Stickstoff- Bindung geknüpft ist,
R⁴ für eine Aminogruppe steht, welche gegebenenfalls durch eine übliche Aminoschutzgruppe geschützt sein kann,
zur Herstellung von in 3-Stellung entsprechend substituierter 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]- 3-cephem-4-carbonsäuren.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55132253A JPS5758689A (en) | 1980-09-25 | 1980-09-25 | Novel preparation of 7-substituted or unsubstituted amino-3-substituted methylcephem carboxylic acids |
JP55158184A JPS5782393A (en) | 1980-11-12 | 1980-11-12 | 7-amino-3-(2-(1,2,3,4-tetrazolyl)methyl)cephem-4-carboxylic acid |
JP55175263A JPS6052755B2 (ja) | 1980-12-13 | 1980-12-13 | 新規セファロスポリン類 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3152931C2 true DE3152931C2 (de) | 1989-10-05 |
Family
ID=27316463
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3152932A Expired - Lifetime DE3152932C2 (de) | 1980-09-25 | 1981-09-23 | |
DE19813137854 Granted DE3137854A1 (de) | 1980-09-25 | 1981-09-23 | Neue cephalosporine, verfahren zur herstellung derselben, zwischenstufen derselben und verfahren zur herstellung der zwischenstufen |
DE3152931A Expired DE3152931C2 (de) | 1980-09-25 | 1981-09-23 | |
DE3152935A Expired - Lifetime DE3152935C2 (de) | 1980-09-25 | 1981-09-23 | |
DE3152934A Expired - Lifetime DE3152934C2 (de) | 1980-09-25 | 1981-09-23 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3152932A Expired - Lifetime DE3152932C2 (de) | 1980-09-25 | 1981-09-23 | |
DE19813137854 Granted DE3137854A1 (de) | 1980-09-25 | 1981-09-23 | Neue cephalosporine, verfahren zur herstellung derselben, zwischenstufen derselben und verfahren zur herstellung der zwischenstufen |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3152935A Expired - Lifetime DE3152935C2 (de) | 1980-09-25 | 1981-09-23 | |
DE3152934A Expired - Lifetime DE3152934C2 (de) | 1980-09-25 | 1981-09-23 |
Country Status (27)
Country | Link |
---|---|
US (4) | US4489072A (de) |
KR (1) | KR860000932B1 (de) |
AR (1) | AR240645A1 (de) |
AT (4) | AT375082B (de) |
AU (3) | AU550330B2 (de) |
CA (2) | CA1204735A (de) |
CH (4) | CH652129A5 (de) |
DD (2) | DD202436A5 (de) |
DE (5) | DE3152932C2 (de) |
DK (1) | DK163877C (de) |
EG (1) | EG17373A (de) |
ES (4) | ES8301998A1 (de) |
FI (2) | FI75575C (de) |
FR (2) | FR2509310B1 (de) |
GB (3) | GB2089339B (de) |
HU (1) | HU185850B (de) |
IN (4) | IN155375B (de) |
IT (1) | IT1172201B (de) |
LU (1) | LU83650A1 (de) |
MX (1) | MX155025A (de) |
NL (1) | NL8104386A (de) |
NO (1) | NO161117C (de) |
NZ (1) | NZ198350A (de) |
PH (5) | PH18072A (de) |
PT (1) | PT73727B (de) |
RO (4) | RO86823B (de) |
SE (5) | SE453090B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703046A (en) * | 1978-09-08 | 1987-10-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds and processes for preparation thereof |
NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
EP0061234A3 (de) * | 1981-03-05 | 1983-11-16 | Beecham Group Plc | Cephalosporin derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate |
EP0081971A3 (de) * | 1981-12-08 | 1984-09-26 | Tanabe Seiyaku Co., Ltd. | Cephalosporinderivate und Verfahren zu ihrer Herstellung |
FI75827C (fi) * | 1982-11-17 | 1988-08-08 | Toyama Chemical Co Ltd | Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart 7-tiazolyl-3-pyrazinylmetylcefalosporin samt en i foerfarandet anvaendbar mellanprodukt. |
US4618606A (en) * | 1982-11-17 | 1986-10-21 | Toyama Chemical Co., Ltd. | Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins |
JPS6064986A (ja) * | 1983-09-20 | 1985-04-13 | Toyama Chem Co Ltd | セファロスポリン類の製造法 |
JPS60190783A (ja) * | 1983-12-21 | 1985-09-28 | Sumitomo Seiyaku Kk | セフエム系化合物 |
GB8406231D0 (en) * | 1984-03-09 | 1984-04-11 | Fujisawa Pharmaceutical Co | Cephem compounds |
AT397086B (de) * | 1984-05-25 | 1994-01-25 | Toyama Chemical Co Ltd | Verfahren zur herstellung von neuen 2-(2-aminothiazol-4-4yl)-2-(syn)-alkoxyimino- acetamiden |
GB2161476B (en) * | 1984-05-25 | 1988-01-27 | Toyama Chemical Co Ltd | 2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins |
FI851934L (fi) * | 1984-05-30 | 1985-12-01 | Ici Plc | Kefalosporinderivat. |
DE3539901A1 (de) * | 1985-11-11 | 1987-05-14 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
JPH064643B2 (ja) * | 1985-12-20 | 1994-01-19 | ファイザー製薬株式会社 | セフアロスポリン化合物 |
US4692517A (en) * | 1986-03-20 | 1987-09-08 | American Home Products Corporation | C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-α-(substituted-oximino)acetyl]cephalosporin derivatives |
EP0265185A3 (de) * | 1986-10-21 | 1990-03-28 | Beecham Group Plc | Cephalosporine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate |
ZA877987B (en) * | 1986-11-12 | 1988-08-31 | Ici Pharma | Antibiotic compounds |
DE3750673T2 (de) * | 1986-11-21 | 1995-03-16 | Ici Pharma | Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate. |
EP0269298B1 (de) * | 1986-11-21 | 1994-10-19 | Ici Pharma | Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate |
US4870168A (en) * | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
GB8816519D0 (en) * | 1987-07-23 | 1988-08-17 | Ici Plc | Antibiotic compounds |
US5232918A (en) * | 1987-07-23 | 1993-08-03 | Imperial Chemical Industries Plc | Cephalosporin derivatives |
GB8811056D0 (en) * | 1988-05-10 | 1988-06-15 | Ici Plc | Antibiotic compounds |
JPH0699443B2 (ja) * | 1989-09-29 | 1994-12-07 | ファイザー製薬株式会社 | セファロスポリン化合物 |
US6800756B2 (en) * | 2002-05-03 | 2004-10-05 | Orchid Chemicals And Pharmaceuticals, Ltd. | Method for the preparation of ceftiofur sodium and its intermediates |
PL1618114T3 (pl) * | 2003-04-16 | 2010-12-31 | Sandoz Ag | Sposoby otrzymywania cefepimy |
US7847093B2 (en) * | 2003-04-16 | 2010-12-07 | Sandoz Ag | Processes for the preparations of cefepime |
US20050288347A1 (en) * | 2004-03-26 | 2005-12-29 | Hodge Carl N | Certain triazole-based compounds, compositions, and uses thereof |
US8198434B2 (en) * | 2008-05-07 | 2012-06-12 | Idexx Laboratories, Inc. | Process for preparing cefsulodin sodium |
CA2828114A1 (en) * | 2010-02-26 | 2011-09-01 | Gary Igor DMITRIENKO | Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof |
CN102351886B (zh) * | 2011-09-07 | 2013-10-16 | 山东罗欣药业股份有限公司 | 头孢特仑新戊酯晶体、其制备方法及含有该晶体的组合物片剂 |
EP4219477A1 (de) | 2013-07-17 | 2023-08-02 | Otsuka Pharmaceutical Co., Ltd. | Cyanotriazolverbindungen |
CN106046026B (zh) * | 2016-06-30 | 2018-07-06 | 济南康和医药科技有限公司 | 一种头孢特仑新戊酯的制备方法 |
CN112645842B (zh) * | 2020-12-25 | 2022-08-19 | 复旦大学 | 一种氰乙酸叔丁酯的连续流制备方法 |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB912541A (en) * | 1958-03-17 | 1962-12-12 | Nat Res Dev | Cephalosporin c compounds |
DE1795484U (de) | 1959-04-21 | 1959-09-10 | Richard Langer | Quertraeger fuer laengsdraehte zum abstuetzen von pflanzen, insbesondere weinreben. |
GB1032641A (en) * | 1962-02-16 | 1966-06-15 | Edward Penley Abraham | Cephalosporins |
GB1057883A (en) * | 1962-07-11 | 1967-02-08 | Glaxo Lab Ltd | Improvements in or relating to antibiotics |
US3226384A (en) * | 1963-01-25 | 1965-12-28 | Nat Res Dev | Cephalosporin ca derivatives |
BE634644A (de) * | 1963-07-10 | |||
US3821206A (en) * | 1966-12-15 | 1974-06-28 | Glaxo Lab Ltd | Cephalosporins having a polyazole substituent |
GB1211694A (en) * | 1966-12-15 | 1970-11-11 | Glaxo Lab Ltd | Derivatives of 7-aminocephalosporanic acid |
GB1360860A (en) * | 1970-07-08 | 1974-07-24 | Ciba Geigy Ag | Cepham compounds process for their manufacture and compositions containing them |
US3932465A (en) * | 1970-07-08 | 1976-01-13 | Ciba-Geigy Corporation | 3-R-methyl-7-amino-ceph-em-4-carboxylic acid compounds |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
US4343937A (en) * | 1971-06-02 | 1982-08-10 | Merck & Co., Inc. | 3-Substituted-7-methoxy-7-amino-3-cephem-4-carboxylic acids |
SU589918A3 (ru) * | 1971-07-14 | 1978-01-25 | Мерк Энд Ко Инк (Фирма) | Способ получени сложного эфира 3-замещенной метил-7-ациломидо-7-метокси-2-цефем -4- карбоноаой кислоты |
JPS5653557B2 (de) * | 1973-10-15 | 1981-12-19 | ||
CH605997A5 (de) * | 1974-08-30 | 1978-10-13 | Ciba Geigy Ag | |
PH15487A (en) * | 1975-02-04 | 1983-01-31 | Fujisawa Pharmaceutical Co | 7((2-hydroxyamino-2-disubstituted phenyl-acetamido)-)3-heterocyclithio-3-cephem-4-carboxylic acids |
GB1547165A (en) * | 1975-08-15 | 1979-06-06 | Beecham Group Ltd | 3-carbamoylbenzyl and 3-(carbamoylpyridylmethyl)-cephems |
GB1575803A (en) * | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
US4165430A (en) * | 1976-03-19 | 1979-08-21 | Glaxo Laboratories Limited | Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group |
JPS5946237B2 (ja) * | 1976-04-02 | 1984-11-10 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
DE2715385A1 (de) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
GB1565941A (en) * | 1977-02-08 | 1980-04-23 | Toyama Chemical Co Ltd | Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids |
DE2710902A1 (de) * | 1977-03-12 | 1978-09-21 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
US4148997A (en) * | 1977-11-07 | 1979-04-10 | Yeda Research And Development Co., Ltd. | 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives |
AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
DE2822861A1 (de) * | 1978-05-26 | 1979-11-29 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
JPS6027677B2 (ja) * | 1978-07-06 | 1985-06-29 | 富山化学工業株式会社 | 7−置換又は非置換アミノ−3−置換チオメチルセフエムカルボン酸類の新規製造法 |
NZ191937A (en) * | 1978-10-27 | 1982-09-07 | Glaxo Group Ltd | Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position |
ES485938A1 (es) * | 1978-11-15 | 1980-07-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de antibioticos de ce- falosporina |
DK78580A (da) * | 1979-02-23 | 1980-08-24 | Glaxo Group Ltd | Fremgangsmaade til fremstilling af cephalosporinantibiotika |
JPS55139387A (en) | 1979-04-19 | 1980-10-31 | Yamanouchi Pharmaceut Co Ltd | Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids |
JPS55153790A (en) | 1979-05-17 | 1980-11-29 | Yamanouchi Pharmaceut Co Ltd | Preparation of 7-amino-3-heterocyclic thiomethyl-delta3- cephem-4-carboxylic acid |
FR2461713A1 (fr) * | 1979-07-19 | 1981-02-06 | Roussel Uclaf | Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
EP0061234A3 (de) * | 1981-03-05 | 1983-11-16 | Beecham Group Plc | Cephalosporin derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate |
EP0135683B1 (de) * | 1981-09-10 | 1987-07-22 | Takeda Chemical Industries, Ltd. | Dioxaphosphole in der Herstellung von Cephalosporinderivaten |
JPS6064986A (ja) * | 1983-09-20 | 1985-04-13 | Toyama Chem Co Ltd | セファロスポリン類の製造法 |
GB2161476B (en) * | 1984-05-25 | 1988-01-27 | Toyama Chemical Co Ltd | 2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins |
CA1293719C (en) * | 1986-09-22 | 1991-12-31 | Takao Takaya | Cephem compounds and processes for preparation thereof |
-
1981
- 1981-09-14 NZ NZ198350A patent/NZ198350A/en unknown
- 1981-09-16 PH PH26215A patent/PH18072A/en unknown
- 1981-09-16 CA CA000386066A patent/CA1204735A/en not_active Expired
- 1981-09-16 GB GB8128011A patent/GB2089339B/en not_active Expired
- 1981-09-17 AU AU75438/81A patent/AU550330B2/en not_active Expired
- 1981-09-19 IN IN1045/CAL/81A patent/IN155375B/en unknown
- 1981-09-23 US US06/304,912 patent/US4489072A/en not_active Expired - Lifetime
- 1981-09-23 DE DE3152932A patent/DE3152932C2/de not_active Expired - Lifetime
- 1981-09-23 DE DE19813137854 patent/DE3137854A1/de active Granted
- 1981-09-23 DE DE3152931A patent/DE3152931C2/de not_active Expired
- 1981-09-23 IT IT49348/81A patent/IT1172201B/it active
- 1981-09-23 DE DE3152935A patent/DE3152935C2/de not_active Expired - Lifetime
- 1981-09-23 NL NL8104386A patent/NL8104386A/xx not_active Application Discontinuation
- 1981-09-23 DE DE3152934A patent/DE3152934C2/de not_active Expired - Lifetime
- 1981-09-24 DK DK421881A patent/DK163877C/da active
- 1981-09-24 MX MX7609A patent/MX155025A/es unknown
- 1981-09-24 SE SE8105658A patent/SE453090B/sv not_active IP Right Cessation
- 1981-09-24 AT AT0410981A patent/AT375082B/de not_active IP Right Cessation
- 1981-09-24 HU HU812759A patent/HU185850B/hu unknown
- 1981-09-24 PT PT73727A patent/PT73727B/pt unknown
- 1981-09-24 LU LU83650A patent/LU83650A1/fr unknown
- 1981-09-24 FI FI812980A patent/FI75575C/fi not_active IP Right Cessation
- 1981-09-24 NO NO813252A patent/NO161117C/no unknown
- 1981-09-24 ES ES505760A patent/ES8301998A1/es not_active Expired
- 1981-09-25 FR FR8118156A patent/FR2509310B1/fr not_active Expired
- 1981-09-25 CH CH6202/81A patent/CH652129A5/de not_active IP Right Cessation
- 1981-09-25 DD DD81233599A patent/DD202436A5/de unknown
- 1981-09-25 RO RO112111A patent/RO86823B/ro unknown
- 1981-09-25 RO RO112112A patent/RO86824B/ro unknown
- 1981-09-25 RO RO112113A patent/RO86825B/ro unknown
- 1981-09-25 CH CH4519/84A patent/CH651837A5/de not_active IP Right Cessation
- 1981-09-25 RO RO81105405A patent/RO82689A/ro unknown
- 1981-09-25 CH CH4521/84A patent/CH652128A5/de not_active IP Right Cessation
- 1981-09-25 DD DD81247292A patent/DD208351A5/de unknown
- 1981-09-25 CH CH4520/84A patent/CH652130A5/de not_active IP Right Cessation
- 1981-09-26 EG EG543/81A patent/EG17373A/xx active
-
1982
- 1982-08-02 ES ES514671A patent/ES8306157A1/es not_active Expired
- 1982-08-02 ES ES514669A patent/ES514669A0/es active Granted
- 1982-08-02 ES ES514670A patent/ES514670A0/es active Granted
- 1982-09-22 FR FR8215992A patent/FR2511377B1/fr not_active Expired
-
1983
- 1983-01-07 AR AR29180883A patent/AR240645A1/es active
- 1983-02-18 AT AT0055583A patent/AT378962B/de not_active IP Right Cessation
- 1983-02-18 AT AT0055683A patent/AT378193B/de not_active IP Right Cessation
- 1983-02-18 AT AT0055483A patent/AT378961B/de not_active IP Right Cessation
- 1983-06-17 PH PH29077A patent/PH20221A/en unknown
- 1983-06-17 PH PH29075A patent/PH19251A/en unknown
- 1983-06-17 PH PH29076A patent/PH19147A/en unknown
- 1983-06-17 PH PH29078A patent/PH18484A/en unknown
- 1983-09-01 CA CA000435930A patent/CA1200541A/en not_active Expired
-
1984
- 1984-01-27 GB GB08402249A patent/GB2135304B/en not_active Expired
- 1984-01-27 GB GB08402250A patent/GB2136420B/en not_active Expired
- 1984-08-29 IN IN601/CAL/84A patent/IN158589B/en unknown
- 1984-08-29 IN IN602/CAL/84A patent/IN158590B/en unknown
- 1984-08-29 IN IN603/CAL/84A patent/IN159126B/en unknown
- 1984-09-26 US US06/654,681 patent/US4673738A/en not_active Expired - Lifetime
-
1985
- 1985-11-13 AU AU49861/85A patent/AU568033B2/en not_active Expired
- 1985-11-13 AU AU49862/85A patent/AU558649B2/en not_active Expired
-
1986
- 1986-01-16 SE SE8600193A patent/SE468479B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600194A patent/SE468476B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600195A patent/SE468477B/sv not_active IP Right Cessation
- 1986-01-16 SE SE8600192A patent/SE468478B/sv not_active IP Right Cessation
- 1986-03-29 KR KR1019860002383A patent/KR860000932B1/ko not_active IP Right Cessation
-
1987
- 1987-01-15 FI FI870153A patent/FI80041C/fi not_active IP Right Cessation
- 1987-03-06 US US07/022,433 patent/US4879381A/en not_active Expired - Lifetime
-
1991
- 1991-05-24 US US07/707,221 patent/US5144027A/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
NICHTS ERMITTELT * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3152931C2 (de) | ||
DE2804896A1 (de) | Verfahren zur herstellung von 7-(substituiert)-amino-3-substituiert- thiomethyl-cephemcarbonsaeuren | |
DE3434096A1 (de) | Neues verfahren zur herstellung von cephalosporinen | |
DE2926664A1 (de) | Neues verfahren zur herstellung von 7-(subst.)-amino-3-subst.-thiomethyl- delta hoch 3 -cephem-4-carbonsaeuren | |
DE2607064A1 (de) | Neue 3-acyloxymethyl-cephem-verbindungen und verfahren zu deren herstellung | |
DE3341591C2 (de) | ||
DE2943437A1 (de) | Cephalosporinverbindungen | |
DE2262500A1 (de) | 3-oxyiminomethylcephalosporinverbindungen | |
CH634327A5 (de) | 7-(aminothiazolyl-acetamido)-cephemcarbonsaeuren, ihre herstellung und arzneimittelzubereitungen. | |
CH627756A5 (en) | Process for the preparation of 3-acyloxymethylcephem compounds | |
CH634326A5 (de) | 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung. | |
AT392792B (de) | Verfahren zur herstellung von cephalosporinderivaten | |
AT384613B (de) | Verfahren zur herstellung von neuen cephalosporinderivaten | |
JPS6210512B2 (de) | ||
JPS6210995B2 (de) | ||
JPH0323552B2 (de) | ||
FR2533216A1 (fr) | Nouvelles cephalosporines, et leurs sels | |
DE2722666A1 (de) | 7-acylamino-3-pyrazinylthiomethyl- 3-cephem-4-carbonsaeure-verbindungen und ihre verwendung zur bekaempfung bakterieller infektionen | |
FR2511373A1 (fr) | Acides 7-(amino substitue ou non)-3-methyl substitue-3-cepheme-4-carboxyliques | |
JPH0454676B2 (de) | ||
CH669383A5 (en) | 2-Amino-4-hydroxy-thiazoline derivs. | |
JPH0357913B2 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
Q172 | Divided out of (supplement): |
Ref country code: DE Ref document number: 3137854 |
|
8110 | Request for examination paragraph 44 | ||
8181 | Inventor (new situation) |
Free format text: SADAKI, HIROSHI NARITA, HIROKAZU IMAIZUMI, HIROYUKI, TOYAMA, JP KONISHI, YOSHINORI, TAKAOKA, JP INABA, TAKIHIRO, NAMERIKAWA, JP HIRAKAWA, TATSUO, TOYAMA, JP TAKI, HIDEO, SAGAMIHARA, JP TAI, MASARU WATANABE, YASUO SAIKAWA, ISAMU, TOYAMA, JP |
|
8176 | Proceedings suspended because of application no: |
Ref document number: 3137854 Country of ref document: DE Format of ref document f/p: P |
|
AC | Divided out of |
Ref country code: DE Ref document number: 3137854 Format of ref document f/p: P |
|
8178 | Suspension cancelled | ||
AC | Divided out of |
Ref country code: DE Ref document number: 3137854 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition |